Aeterna Zentaris (AEZS) News Today $3.00 -0.20 (-6.25%) (As of 11/19/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CSCI:CA COSCIENS Biopharma Inc.September 18, 2024 | seekingalpha.comAeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.August 6, 2024 | globenewswire.comChimerix Inc (CXF.BE)July 19, 2024 | finance.yahoo.comAeterna Zentaris Announces Results of Virtual 2024 Meeting of ShareholdersJuly 16, 2024 | globenewswire.comAeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyJune 13, 2024 | globenewswire.comShareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to ShareholdersJune 7, 2024 | prnewswire.comAeterna Zentaris and Ceapro Complete Merger TransactionJune 3, 2024 | globenewswire.comAeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption DateMay 29, 2024 | globenewswire.comAeterna Zentaris Inc: Aeterna Zentaris Announces Details Regarding Transaction with CeaproMay 27, 2024 | finanznachrichten.deAeterna Zentaris Announces Details Regarding Transaction with CeaproMay 17, 2024 | finance.yahoo.comAeterna Zentaris Announces Details Regarding Transaction with CeaproMay 17, 2024 | globenewswire.comAeterna Zentaris Inc: Aeterna Zentaris Reports First Quarter 2024 Financial ResultsMay 15, 2024 | finanznachrichten.deAeterna Zentaris: Q1 Earnings SnapshotMay 14, 2024 | washingtonpost.comAeterna Zentaris Reports First Quarter 2024 Financial ResultsMay 14, 2024 | globenewswire.comTrading was temporarily halted for "AEZS" at 07:05 PM with a stated reason of "News pending."May 3, 2024 | marketbeat.comAeterna Zentaris Announces Effective Date of Share ConsolidationMay 1, 2024 | globenewswire.com12 ChatGPT Penny Stock Picks Right NowApril 28, 2024 | finance.yahoo.comAuxly Cannabis Group: Top 10 Undervalued Healthcare Sector Stocks on TSX (XLY)April 2, 2024 | theglobeandmail.comCeapro Receives Final Court Approval for Merger with Aeterna ZentarisMarch 28, 2024 | globenewswire.comAEterna Zentaris: Q4 Earnings InsightsMarch 27, 2024 | benzinga.comAeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyMarch 27, 2024 | globenewswire.comAeterna Zentaris Inc: Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsMarch 13, 2024 | finanznachrichten.deAeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsMarch 12, 2024 | globenewswire.comAeterna Zentaris Inc.February 28, 2024 | thestreet.comLeading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical CompanyFebruary 26, 2024 | globenewswire.comAeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with CeaproFebruary 15, 2024 | globenewswire.comTrading was temporarily halted for "AEZS" at 07:12 AM with a stated reason of "News pending."December 14, 2023 | marketbeat.comAEterna Zentaris Inc AEZSNovember 14, 2023 | morningstar.comAeterna Zentaris GAAP EPS of -$0.85November 9, 2023 | msn.comAeterna Zentaris Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 | finance.yahoo.comAEterna Zentaris: Stocks trading at Less Than Cash Value on TSX (AEZS)November 6, 2023 | theglobeandmail.comAEterna Zentaris: Top 10 Undervalued Biotechnology Industry Stocks (AEZS)October 30, 2023 | theglobeandmail.comAeterna Zentaris to Participate at the Virtual Investor Ask the CEO ConferenceOctober 11, 2023 | finance.yahoo.comClosing Bell: Aeterna Zentaris Inc down on Monday (AEZS)September 12, 2023 | theglobeandmail.comAeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 5, 2023 | finance.yahoo.comClosing Bell: Aeterna Zentaris Inc flat on Tuesday (AEZS)August 15, 2023 | theglobeandmail.comH.C. Wainwright Keeps Their Buy Rating on Aeterna Zentaris (AEZS)August 10, 2023 | markets.businessinsider.comAeterna Zentaris (AEZS) Reports Q2 Loss, Tops Revenue EstimatesAugust 9, 2023 | finance.yahoo.comAeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate UpdateJuly 13, 2023 | finance.yahoo.comAeterna Zentaris Inc: Aeterna Zentaris Announces Results of Virtual 2023 Meeting of ShareholdersJune 15, 2023 | finanznachrichten.deClosing Bell: Aeterna Zentaris Inc down on Friday (AEZS)May 26, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc down on Tuesday (AEZS)May 17, 2023 | theglobeandmail.comAeterna Zentaris Announces Virtual 2023 Meeting of ShareholdersMay 15, 2023 | finance.yahoo.comH.C. Wainwright Reaffirms Their Buy Rating on Aeterna Zentaris (AEZS)May 12, 2023 | markets.businessinsider.comAeterna Zentaris Inc: Aeterna Zentaris Reports First Quarter 2023 Financial ResultsMay 10, 2023 | finanznachrichten.deAeterna Zentaris Reports First Quarter 2023 Financial ResultsMay 9, 2023 | finance.yahoo.comClosing Bell: Aeterna Zentaris Inc down on Wednesday (AEZS)April 27, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc up on Thursday (AEZS)April 6, 2023 | theglobeandmail.comClosing Bell: Aeterna Zentaris Inc up on Wednesday (AEZS)April 6, 2023 | theglobeandmail.comAeterna (AEZS) Falls 5% on US Sales Halt of Growth Hormone DrugApril 6, 2023 | finance.yahoo.com Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. AEZS Media Mentions By Week AEZS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEZS News Sentiment▼0.000.46▲Average Medical News Sentiment AEZS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEZS Articles This Week▼00▲AEZS Articles Average Week Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ENLV News PIRS News PULM News GLYC News IBIO News CYTH News SPRB News UBX News MEIP News FNCH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEZS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aeterna Zentaris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aeterna Zentaris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
